Skip to main content
Clinical Trials/IRCT20190312043036N2
IRCT20190312043036N2
Recruiting
未知

Comparative efficacy of unified protocol of transdiagnostic psychotherapy, metacognitive therapy, and mirtazapine treatment in the frequency and severity of physical symptoms, psychological symptoms, and quality of life in functional dyspepsia disorder

Shahid Beheshti University of Medical Sciences0 sites220 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Functional dyspepsia.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
220
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Suffering functional dyspepsia without comorbid diseases such as IBS or other digestive diseases if IBS was comorbid, the onset of functional dyspepsia symptoms would be prior to IBS
  • Not having any variety of chronic somatic diseases
  • No simultaneous use of other psychiatric drugs
  • No dependency on or abusing substance
  • Partial adherence to diet and exercise
  • Absence of severe psychiatric disorders
  • Age range between 18 and 55
  • Having reading and writing skills
  • 6 months lasted from the definite diagnosis of functional dyspepsia for all patients All patients had not taken any psychiatric drug and psychotherapy during the last 3 months ago
  • 80\-90% adherence to the targeted treatments and treatment as usual in any groups

Exclusion Criteria

  • Unwillingness to participate in the research for any reason
  • Inability of the patient to access the medical center
  • Having chronic physical impairment or physical inability
  • Having a severe mental disorder
  • Substance use or dependence
  • Patients need to take any medicine other than the prescribed drugs in the study during the study
  • Infected to H\-pylori
  • Being pregnant
  • Having any physiopathology in Endoscopy
  • Having any severe and intolerable side effects

Outcomes

Primary Outcomes

Not specified

Similar Trials